JP Morgan's analysis indicates that major Chinese life and non-life insurers showed strong core solvency in the first quarter of 2026, with life insurers resuming the disclosure of the 'residual margin'. Most insurers demonstrated resilience in reserve balances compared to December 2022, suggesting a positive outlook for core earnings growth. The investment ratings for major insurers are generally 'Overweight', reflecting confidence in their performance.
